Clearmind aims to initiate clinical trials with CMND-100 by year’s end Vancouver, May 13, 2022 — Clearmind Medicine Inc. (CSE: CMND, OTC Pink:CMNDF, FSE: CWY0) (“Clearmind” or the „Company„), a […]
Read more
Two pre-clinical trials based on MEAI exhibited a significant suppressive effect on alcohol consumption in mice… WEITERLESEN
Read moreThe companies have begun the Collaboration with a joint pre-clinical study and are expecting its results potentially to deepen the Collaboration between the parties. TORONTO, March 08, 2022 (GLOBE NEWSWIRE) […]
Read more